EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis (Q38314944)

2 September 2017

EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis (English)

1 reference

2 September 2017

1 reference

1 reference

M Tanaka

1

1 reference

2 September 2017

H I Suzuki

2

1 reference

2 September 2017

J Shibahara

3

1 reference

2 September 2017

A Kunita

4

1 reference

2 September 2017

T Isagawa

5

1 reference

2 September 2017

A Yoshimi

6

1 reference

2 September 2017

M Kurokawa

7

1 reference

2 September 2017

K Miyazono

8

1 reference

2 September 2017

H Aburatani

9

1 reference

2 September 2017

S Ishikawa

10

1 reference

2 September 2017

M Fukayama

11

1 reference

2 September 2017

language of work or name

English

0 references

publication date

10 June 2013

1 reference

2 September 2017

1 reference

2 September 2017

33

1 reference

2 September 2017

19

1 reference

2 September 2017

2454-2463

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.204

2 September 2017

0 references

cites work

Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Significance of mucin expression in pancreatobiliary neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Claudin-18 is an early-stage marker of pancreatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Evi1 forms a bridge between the epigenetic machinery and signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

MatInspector and beyond: promoter analysis based on transcription factor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Emerging complexity of microRNA generation cascades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Modulation of microRNA processing by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Role of miR-143 targeting KRAS in colorectal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

The Evi1, microRNA-143, K-Ras axis in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Ras activity levels control the development of pancreatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.204

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.204

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference